These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19060722)

  • 1. Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders.
    Serretti A; Chiesa A; Calati R; Perna G; Bellodi L; De Ronchi D
    Int Clin Psychopharmacol; 2009 Jan; 24(1):1-18. PubMed ID: 19060722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between SERTPR and stressful life events on response to antidepressant treatment.
    Mandelli L; Marino E; Pirovano A; Calati R; Zanardi R; Colombo C; Serretti A
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):64-7. PubMed ID: 18815011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the 5-HTTLPR polymorphism in the serotonin transporter gene on major depressive disorder and related comorbid disorders.
    Verhagen M; van der Meij A; Janzing JG; Arias-Vásquez A; Buitelaar JK; Franke B
    Psychiatr Genet; 2009 Feb; 19(1):39-44. PubMed ID: 19125107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology.
    Alexander JL; Dennerstein L; Kotz K; Richardson G
    Expert Rev Neurother; 2007 Nov; 7(11 Suppl):S45-58. PubMed ID: 18039068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anxiety disorders in late life.
    Sadavoy J; LeClair JK
    Can J Psychiatry; 1997 Jun; 42 Suppl 1():28S-34S. PubMed ID: 9220127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids and anxiety disorders.
    Ross BM
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):309-12. PubMed ID: 19906519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacotherapy of anxiety disorders].
    Philipp M
    Z Arztl Fortbild (Jena); 1995 May; 89(2):147-50. PubMed ID: 7610681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do comorbid anxiety disorders impact treatment planning for outpatients with major depressive disorder?
    Petersen T; Andreotti CF; Chelminski I; Young D; Zimmerman M
    Psychiatry Res; 2009 Aug; 169(1):7-11. PubMed ID: 19596155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy for alcohol-related disorders: what clinicians should know.
    Mariani JJ; Levin FR
    Harv Rev Psychiatry; 2004; 12(6):351-66. PubMed ID: 15764470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety and depressive disorders in college youth.
    Bhave S; Nagpal J
    Pediatr Clin North Am; 2005 Feb; 52(1):97-134, ix. PubMed ID: 15748927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of psychiatric comorbidity in fibromyalgia.
    Arnold LM
    Curr Psychiatry Rep; 2006 Jun; 8(3):241-5. PubMed ID: 19817076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses.
    Papakostas GI; Ongür D; Iosifescu DV; Mischoulon D; Fava M
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):135-42. PubMed ID: 15013029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living with anxiety disorders: as good as it gets...?
    Moreno FA; Delgado PL
    Bull Menninger Clin; 2000; 64(3 Suppl A):A4-21. PubMed ID: 11002527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy and mood disorders.
    Kanner AM
    Epilepsia; 2007; 48 Suppl 9():20-2. PubMed ID: 18047595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological management of mood and anxiety disorders in headache patients.
    Griffith JL; Razavi M
    Headache; 2006 Oct; 46 Suppl 3():S133-41. PubMed ID: 17034391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.
    Helton SG; Lohoff FW
    Pharmacogenomics; 2015; 16(5):541-53. PubMed ID: 25916524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study.
    Huang KL; Su TP; Chen TJ; Chou YH; Bai YM
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):401-9. PubMed ID: 19566773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis.
    Uguz F; Akman C; Kucuksarac S; Tufekci O
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):50-5. PubMed ID: 19154212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.